EP 1067948 A1 20010117 - USE OF EXTRACTS OF BEARBERRY LEAVES (ARCTOSTAPHYLOS UVA URSI), BIRCH LEAVES (BETULA), HORSETAIL (EQUISETUM) AND STINGING NETTLE (URTICA)
Title (en)
USE OF EXTRACTS OF BEARBERRY LEAVES (ARCTOSTAPHYLOS UVA URSI), BIRCH LEAVES (BETULA), HORSETAIL (EQUISETUM) AND STINGING NETTLE (URTICA)
Title (de)
VERWENDUNG VON BÄRENTRAUBENBLÄTTERN (ARCTOSTAPHYLOS UVA URSI)-, BIRKENBLÄTTER (BETULA)-,SCHACHTELHALKRAUT (EQUISETUM)- UND BRENNESSEL (URTICA)-EXTRAKTE
Title (fr)
UTILISATION D'EXTRAITS DE FEUILLES DE BUSSEROLE(ARCTOSTAPHYLOS UVA URSI), DE FEUILLES DE BOULEAU (BETULA), DE PRELE (EQUISETUM) ET D'ORTIE BRULANTE (URTICA)
Publication
Application
Priority
- DE 19814905 A 19980402
- EP 9902153 W 19990326
Abstract (en)
[origin: DE19814905A1] The invention relates to the use of extracts of bearberry leaves (Arctostaphylos uva ursi), birch leaves (Betula), horsetail (Equisetum) and stinging nettle (Urtica), especially dry extracts from the fresh or dried plants, to produce medicaments for treating or preventing (protecting against) damage caused to organs and tissue by radiation (radioprevention, radioprotection), infection (infection prophylaxis) and chemical action (chemoprevention, chemoprotection), especially damage to the O-MALT system of the small bowel (inflammatory diseases, enteritis regionalis Crohn), the lungs (inflammation, disease), the bronchial tubes and the rhinopharynx (rhino-pharyngo-bronchitis, rhinitis, pharyngitis, sinusitis), the bone marrow (aplasia of the bone marrow), the thymus (dysfunction, aplasia or hypoplasia resulting from damage caused by medicaments or radiation), the liver (atrophy, necrosis), for treating/preventing hepatitis A, B and C, for damage to the pancreas, insufficiency of the exocrine, secretory functions of proteases, esterases, carbohydrases and nucleases and impairment of the carbohydrate metabolism (Langerhans' islands), damage to the kidneys (insufficiency), and generally immunosuppressed conditions, for cellular immunostimulation, for treating leucocytopenia, granulocytopenia, lymphoctopenia, thrombocytopenia, erythrocytopenia (infect anaemia, tumour anaemia i.a.), immunoglobulin deficiency conditions, and for conditions resulting from AIDS, tumours and diseases with a suppressed immune system.
IPC 1-7
IPC 8 full level
A61K 36/00 (2006.01); A61K 36/11 (2006.01); A61K 36/185 (2006.01); A61K 36/28 (2006.01); A61K 36/38 (2006.01); A61K 36/45 (2006.01); A61P 31/18 (2006.01); A61P 37/04 (2006.01)
CPC (source: EP)
A61K 36/11 (2013.01); A61K 36/185 (2013.01); A61K 36/28 (2013.01); A61K 36/38 (2013.01); A61K 36/45 (2013.01); A61P 31/18 (2017.12); A61P 37/04 (2017.12); Y02A 50/30 (2017.12)
Citation (search report)
See references of WO 9951251A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB IT LI LU NL SE
DOCDB simple family (publication)
DE 19814905 A1 19991007; AU 3703099 A 19991025; EP 1067948 A1 20010117; WO 9951251 A1 19991014
DOCDB simple family (application)
DE 19814905 A 19980402; AU 3703099 A 19990326; EP 9902153 W 19990326; EP 99919156 A 19990326